MaxCyte, Inc. - Filing of Form 10-Q

RNS Number: 0855 Z MaxCyte, Inc. 11 May 2023. MaxCyte announces filing of Form 10- Q for the quarterly period ended March 31, 2023. ROCKVILLE, MD, May 11, 2023- MaxCyte, Inc.,, a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development, and commercialization of next-generation cell therapeutics and...